In the future, it will be necessary to explore whether CD7-loss T cells, especially newly emerging CD7-negative T cells after CD7 CAR-T cell treatment, remain resistant to opportunistic infections or how to improve the function of such T cells to improve patients' survival rates. Here, CD7 is linked to Opportunistic infection.